RecruitingNot ApplicableNCT06523569

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Sponsor

Northwestern University

Enrollment

120 participants

Start Date

Nov 7, 2024

Study Type

INTERVENTIONAL

Conditions

Pre-Eclampsia Eclampsia Gestational Hypertension Hypertension in Pregnancy

Summary

The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 99 Years

Inclusion Criteria3

Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital)
Live birth at any gestational age
Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension)

Exclusion Criteria5

HELLP syndrome
History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease)
Current Omron remote patient monitoring or Noom user
BMI\<18.5 kg/m2 at enrollment
Inadequate gestational weight gain or gestational weight loss

Interventions

OTHERDigital Blood Pressure Monitoring System

As a part of the bundled digital health intervention, the participant will receive instructions on how to follow a link in their electronic patient portal that will allow direct input of home blood pressure readings for clinical review.

OTHERMobile health application

As a part of the bundled digital health intervention, the participant will be given a lifestyle change mobile health application.

Locations(1)

Northwestern University, Dept. of Cardiology

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06523569

Related Trials

Placental Biology in Health and Disease

NCT074703201 location

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

NCT067851161 location